Discontinued drugs in 2008: endocrine and metabolic.

about

Discontinued drugs in 2008: endocrine and metabolic.

Item

http://www.wikidata.org/entity/Q38449224

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Discontinued drugs in 2008: endocrine and metabolic.

@en

type

Item

label

Discontinued drugs in 2008: endocrine and metabolic.

@en

prefLabel

Discontinued drugs in 2008: endocrine and metabolic.

@en

P1476

Discontinued drugs in 2008: endocrine and metabolic.

@en

P2093

Jerry R Colca

http://www.w3.org/2001/XMLSchema#string

P2860

The endocannabinoid system as an emerging target of pharmacotherapy

Squalene synthase inhibition: a novel target for the management of dyslipidemia

Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.

Treatment with a cholesterol absorption inhibitor (FM-VP4) reduces body mass and adipose accumulation in developing and pre-obese mice.

Thiazolidinediones.

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.

Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity.

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.

The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes.

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.

P304

1243-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903132673

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19678796

http://www.w3.org/2001/XMLSchema#string

Discontinued drugs in 2008: endocrine and metabolic.

about

Discontinued drugs in 2008: endocrine and metabolic.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698